ACE2 and COVID-19: GSH has also been shown to reduce levels of TNF-α, a proinflammatory cytokine found upregulated in COVID-19 which triggers cytokine release syndrome (CRS) and facilitates SARS-CoV-2 binding with angiotensin-converting enzyme 2 (ACE2) [19,20].